The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Share News (PXS)

Share Price Information for Provexis (PXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.60
Bid: 0.55
Ask: 0.65
Change: 0.015 (2.56%)
Spread: 0.10 (18.182%)
Open: 0.585
High: 0.00
Low: 0.00
Prev. Close: 0.585
PXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS SUMMARY: Provexis, Thruvision loss narrows; Unigel revenue up

Fri, 30th Sep 2022 21:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Kropz PLC - African phosphate developer - Pretax loss in the first half 2022 widens to USD60.9 million from USD7.4 million a year before. Can be put down to a USD44.7 million loss on the disposal of a subsidiary.

----------

Provexis PLC - Reading, England-based producer of heart-health functional food ingredient Fruitflow - Pretax loss in the first year to March 31 narrows to GBP299,132 from GBP361,803 the year before. Revenue falls 16% to GBP426,168 from GBP505,330. Explains the decrease in revenue with a fall from income received from its alliance agreement with DSM. Expects that the new gut microbiome patent application will have a strongly beneficial effect on current and future commercial prospects.

----------

Valereum PLC - Gibraltar-based blockchain technology - Pretax loss in the six months to June 30 widens to GBP1.0 million from GBP501,478 a year before, as administrative expenses jump to GBP1.0 million from GBP519,532. Records no revenue, slipping from GBP11,210. "We remain focused on establishing the Gibraltar Stock Exchange not only as one of the world's first fully regulated exchanges crossing the digital divide, but also linking into markets not touched by other European exchanges," Chair Richard Poulden comments.

----------

Rurelec PLC - London-based power producer with operations in Latin America - Swings to a pretax profit of GBP697,000 in the first half of 2022 from a loss of GBP875,000 a year before. Attributes this to a foreign exchange gain of GBP1.2 million. "The board continues to pursue measures to unlock the inherit value of the company through selling or developing assets and managing cash receipts from the power generation plant in Argentina. We are conscious that the economic situation in Argentina remains challenging and we continue to monitor the impact on our operating asset there," Executive Director Andy Coveney says.

----------

Stranger Holdings PLC - London-based investment company intending to acquire a target company, business or asset in the industrial or service sector - Pretax loss for the year to March 31 widens to GBP602,000 from GBP432,000 the year before. Administrative expenses jump to GBP457,000 versus GBP344,000.

----------

Unigel Group PLC - Eastbourne, East Sussex-based manufacturer of thixotropic gels for the fibre optic cable industry - Expects revenue of GBP17.9 million for the first half of 2022, up 87% year-on-year. Anticipates a pretax profit of GBP940,000, up 94% on a year ago. "The directors are pleased with the growth achieved in the first half of 2022 which arose from a combination of higher selling prices, new product introduction and new customer acquisition. Management continue to optimise the manufacturing capability of the group and continue to improve its product range through its in-house research and development team," the company states.

----------

Hawkwing PLC - London-based cash shell - Pretax loss for the first half of 2022 widens to GBP547,000 from GBP190,000 a year before. Records finance costs of GBP938,000.

----------

Xeros Technology Group PLC - Rotherham, England-based environmental technology firm - In the six months to June 30, pretax loss widens to GBP4.2 million from GBP3.4 million. Administrative expenses jump to GBP4.2 million versus GBP3.6 million. Revenue falls to GBP40,000 from GBP341,000. Blame this on licensing revenue, which fell 92%.

----------

Kendrick Resources PLC - London-based exploration company - Pretax loss in the first half of 2022 widens to GBP184,700 from GBP169,362 a year before. Operating expenses jump to GBP173,828 versus GBP153,408. Records no revenue, unchanged from a year before. Plans to build a long-term energy metals business in Scandinavia to deliver energy metals to Europe to help enable its renewable energy transformation

----------

Thruvision Group PLC - Abingdon, England-based people-screening technology - For the year which ends March 31, pretax loss narrows to GBP1.9 million from GBP2.8 million a year before. Revenue rises 25% to GBP8.4 million from GBP6.7 million. Credits this to a strong performance, driven by significant growth in Profit Protection. Believes it is well positioned to deliver good growth.

----------

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
5 Aug 2012 14:10

Sunday share tips: GKN, Provexis, BP

First-half numbers from specialist engineer GKN beat market expectations, with pre-tax profits leaping 43 per cent. Nigel Stein, chief executive, also gave some upbeat interviews, indicating that, while many of GKN's customers were cautious about the rest of 2012, "no one is pressing alarm buttons"

Read more
31 Jul 2012 11:51

Small caps: IndigoVision, Silence Therapeutics, Air Partner...

Air Partner, a provider of air charter services, has said underlying profit before tax for the year is expected to meet its forecasts. The firm's cost reduction programme is also now nearly complete and will realise 'significant cost savings' in the next financial year, with a one off restructuring

Read more
14 Feb 2012 10:12

Small caps round-up: Provexis, CareTech, Nanoco ...

Sports nutrition specialist Provexis said an industrial scale production of Fruitflow powder, was successfully completed in 2012. Fruitflow is Provexis's tomato extract which inhibits platelet aggregating and therefore reduces the chance of heart disease. Provexis has identified a potential applic

Read more
15 Dec 2011 15:01

Sector movers: Old Mutual boosts life insurers after Nordic sale

Life insurance stocks were on the rise on Thursday afternoon, helped by FTSE 100 savings, investment and insurance group Old Mutual. Shares in Old Mutual roared higher on Thursday after announcing that it is to sell its Nordic business Skandia AB for £2.1bn in an effort to "reduce complexity" and p

Read more
1 Dec 2011 12:40

First half losses grow at Provexis

Medical food and dietary supplement developer Provexis disappointed investors with widened losses for the six months ended 30 September. The share price fell 23.08% to 1.75p by 13:05. The losses, which grew from £1m to £1.5m, came despite revenues doubling from £0.7m to £1.5m after costs rose signi

Read more
17 Jun 2011 09:20

Provexis hurt by R&D costs, acquisition fails to inspire

Medical food and dietary supplement developer Provexis reported a wider pre-tax loss, hurt by increased research and development expenses, while its plans to acquire a sports nutrition products manufacturer failed to inspire investors. For the year ended March 31, Provexis posted a loss before tax

Read more
16 Dec 2010 07:49

Rising R&D costs hurt Provexis

Medical food and dietary supplement developer Provexis said pre-tax losses almost doubled as it increased research and development spending. Investment in R&D increased to £612,171 in the period, up from £289,125 in the same period last year, as the group broadens its product pipeline. The group

Read more
9 Sep 2010 16:23

Provexis to exhibit Fruitflow later this year

The board of functional and medical food company Provexis has set itself the task in the coming year of maximising the commercial opportunity for Fruitflow, its patented tomato extract which aims to improve heart health. The marketing strategy for Fruitflow is now being finalised and the technology

Read more
26 Jul 2010 16:55

Provexis widens Fruitflow approvals

Functional foods developer Provexis has gained approval from the European Food Safety Authority (EFSA) to use its Fruitflow technology in dietary supplements. Fruitflow was already allowed to be used in drinks by the EFSA. Provexis can also use the claim that Fruitflow "helps maintain normal plate

Read more
26 Jul 2010 07:33

Provexis: Fruitflow Gets Further European Food Safety Approval

LONDON (Dow Jones)--Provexis PLC (PXS.LN), a company which focuses on the discovery, development and licensing of scientifically-proven functional food, medical food and dietary supplement technologies, Monday announces a widening of the European Food Safety Authority (EFSA) opinion on the Company's

Read more
22 Jun 2010 07:33

Provexis Raises GBP88,869 In Draw Down Of Funds, Equity Issue

LONDON (Dow Jones)--Provexis PLC (PXS.LN), which focuses on the discovery, development and licensing of scientifically-proven functional food, medical food and dietary supplement technologies, said Tuesday it has raised net proceeds of GBP88,869 by drawing down on its Equity Financing Facility with

Read more
31 Mar 2010 17:07

London close: Up and down day for London

The movements of the blue-chip index looked like they were being directed by the grand old Duke of York on Wednesday, with the market finishing neither up nor down. British Sky Broadcasting (BSkyB) was predictably outraged at the decision by telecoms regulator Ofcom to order it to make its two top

Read more
31 Mar 2010 16:08

Small caps round-up: Provexis, Renew, Source BioSciences...........

Functional foods developer Provexis expects to have net cash of £7m at the end of March 2010. It has also entered into a three-year, £25m equity financing facility provided by Evolution Securities through its subsidiary Darwin Strategic. This could be used to help finance acquisitions. Renew Holdi

Read more
9 Mar 2010 08:45

Provexis surges on test results

Shares in medical food and dietary supplement developer Provexis shot up on Tuesday after it published the results of a trial of its Fruitflow product, which is designed to reduce the risk of heart attack, stroke and venous thrombosis. Fruitflow, a tomato extract which counters unwanted clot forma

Read more
17 Dec 2009 12:03

Small cap round-up: ILX, Ideal Shopping, Provexis...

E-learning company ILX has won three contracts that are expected to produce revenues of more than £0.27m over the life of the contracts. The first contract is to provide project management training to a major government department over a period of three years. The other two contracts are for overse

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.